Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Aug 15;330(7):626-635.
doi: 10.1001/jama.2023.13140.

Manchester Procedure vs Sacrospinous Hysteropexy for Treatment of Uterine Descent: A Randomized Clinical Trial

Collaborators, Affiliations
Randomized Controlled Trial

Manchester Procedure vs Sacrospinous Hysteropexy for Treatment of Uterine Descent: A Randomized Clinical Trial

Rosa A Enklaar et al. JAMA. .

Erratum in

Abstract

Importance: In many countries, sacrospinous hysteropexy is the most commonly practiced uterus-preserving technique in women undergoing a first operation for pelvic organ prolapse. However, there are no direct comparisons of outcomes after sacrospinous hysteropexy vs an older technique, the Manchester procedure.

Objective: To compare success of sacrospinous hysteropexy vs the Manchester procedure for the surgical treatment of uterine descent.

Design, setting, and participants: Multicenter, noninferiority randomized clinical trial conducted in 26 hospitals in the Netherlands among 434 adult patients undergoing a first surgical treatment for uterine descent that did not protrude beyond the hymen.

Interventions: Participants were randomly assigned to undergo sacrospinous hysteropexy (n = 217) or Manchester procedure (n = 217).

Main outcomes and measures: The primary outcome was a composite outcome of success, defined as absence of pelvic organ prolapse beyond the hymen in any compartment evaluated by a standardized vaginal support quantification system, absence of bothersome bulge symptoms, and absence of prolapse retreatment (pessary or surgery) within 2 years after the operation. The predefined noninferiority margin was 9%. Secondary outcomes were anatomical and patient-reported outcomes, perioperative parameters, and surgery-related complications.

Results: Among 393 participants included in the as-randomized analysis (mean age, 61.7 years [SD, 9.1 years]), 151 of 196 (77.0%) in the sacrospinous hysteropexy group and 172 of 197 (87.3%) in the Manchester procedure group achieved the composite outcome of success. Sacrospinous hysteropexy did not meet the noninferiority criterion of -9% for the lower limit of the CI (risk difference, -10.3%; 95% CI, -17.8% to -2.8%; P = .63 for noninferiority). At 2-year follow-up, perioperative outcomes and patient-reported outcomes did not differ between the 2 groups.

Conclusions: Based on the composite outcome of surgical success 2 years after primary uterus-sparing pelvic organ prolapse surgery for uterine descent, these results support a finding that sacrospinous hysteropexy is inferior to the Manchester procedure.

Trial registration: TrialRegister.nl Identifier: NTR 6978.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.
Figure 1.. Illustration of Sacrospinous Hysteropexy and Manchester Procedure Techniques
Figure 2.
Figure 2.. Participant Flow
POP-Q indicates Pelvic Organ Prolapse Quantification. aPatients aged 18 years or older with symptomatic pelvic organ prolapse planning to undergo a vaginal uterus-preserving operation were screened for inclusion. There were no screening logs of eligible patients maintained at the 26 participating centers. For privacy reasons, the ethics committee did not permit collection of any anonymized data of screened nonparticipants. This made collection of the number of eligible patients prone to missing and double counts. bOther procedures included vaginal hysterectomy (n = 1), anterior colporrhaphy and midurethral sling (n = 1), anterior and posterior colporrhaphy and perineal repair (n = 1), and posterior colporrhaphy (n = 1). cTwo patients in the Manchester procedure group did not complete 2-years follow-up but were analyzed as having not met the composite outcome of surgical success. The patients underwent retreatment for recurrent pelvic organ prolapse before loss to follow-up and therefore did meet the criterion for the composite outcome.

Comment in

References

    1. Olsen AL, Smith VJ, Bergstrom JO, et al. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89(4):501-506. doi: 10.1016/S0029-7844(97)00058-6 - DOI - PubMed
    1. Smith FJ, Holman CD, Moorin RE, Tsokos N. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol. 2010;116(5):1096-1100. doi: 10.1097/AOG.0b013e3181f73729 - DOI - PubMed
    1. de Boer TA, Slieker-Ten Hove MC, Burger CW, et al. The prevalence and factors associated with previous surgery for pelvic organ prolapse and/or urinary incontinence in a cross-sectional study in the Netherlands. Eur J Obstet Gynecol Reprod Biol. 2011;158(2):343-349. doi: 10.1016/j.ejogrb.2011.04.029 - DOI - PubMed
    1. NICE guidance—urinary incontinence and pelvic organ prolapse in women: management. BJU Int. 2019;123(5):777-803. doi: 10.1111/bju.14763 - DOI - PubMed
    1. Enklaar RA, van Ijsselmuiden MN, IntHout J, et al. Practice pattern variation: treatment of pelvic organ prolapse in the Netherlands. Int Urogynecol J. 2022;33(7):1973-1980. doi: 10.1007/s00192-021-04968-8 - DOI - PMC - PubMed